img

Hepcdac Tablet By Cipla Pharma

( 0 out of 5 )

Hepcdac 60mg Tablet is an antiviral medication manufactured by Cipla Ltd, used in the treatment of chronic hepatitis C virus (HCV) infection. It contains Daclatasvir, a potent NS5A inhibitor that interferes with the replication of the HCV within liver cells. Daclatasvir works by blocking the NS5A protein, which is essential for viral replication and assembly.

Hepcdac 60mg by cipla Details :

Category Anti Cancer Drugs
Brand Cipla
Ingredient Daclatasvir
Prescription Required Yes
Strength 60mg
Package 28 Tablets
Category:

How Does Hepcdac 60mg Work:

Hepcdac 60mg works by targeting and inhibiting the NS5A protein, which is crucial for the replication and assembly of the hepatitis C virus (HCV). The active ingredient, daclatasvir, is a potent NS5A inhibitor that interferes with the virus’s ability to replicate within liver cells.

Benefits of Hepcdac 60mg:

Hepcdac 60mg offers significant benefits in the treatment of chronic hepatitis C virus (HCV) infection. The primary advantage of this medication lies in its ability to inhibit the NS5A protein, which is essential for HCV replication. By blocking this protein, daclatasvir, the active ingredient in Hepcdac, effectively reduces the viral load, leading to the clearance of the virus from the body when used in combination with other antiviral medications like sofosbuvir.

Common Side Effects:

The most common side effects of Hepcdac 60mg are:

  • Headache
  • Fatigue (tiredness)
  • Nausea
  • Diarrhea
  • Insomnia (difficulty sleeping)
  • Loss of appetite
  • Dizziness

Other side effects of Hepcdac 60mg can include:

  • Liver enzyme elevation (ALT, AST)
  • Hepatitis B reactivation (in co-infected patients)
  • Severe rash or skin reactions
  • Itching (pruritus)
  • Blistering or peeling skin
  • Anemia (especially when used with ribavirin)
  • Muscle pain or joint pain
  • Depression or mood changes

Who Should Not Take Hepcdac 60mg:

Hepcdac 60mg (daclatasvir) should not be taken by individuals who are allergic to daclatasvir or any of the tablet’s inactive ingredients. It is also not recommended for people with severe liver problems or liver failure, as the medication may worsen liver function. Hepcdac should be used only in combination with other antiviral medications like sofosbuvir and not as monotherapy.

How To Take Hepcdac 60mg:

Hepcdac 60mg (daclatasvir) should be taken exactly as prescribed by a healthcare provider. The typical dosage is one tablet once daily, with or without food. It is important to take the tablet at the same time each day to ensure consistent levels of the medication in the body. Hepcdac is generally prescribed as part of a combination therapy, often with sofosbuvir or other antiviral drugs, depending on the patient’s specific condition and genotype of hepatitis C.

There are no reviews yet.

Add a Review

Your rating